Researchers evaluated an electronic health record-based intervention that identified patients with metastatic cancer for a multipronged approach to their in-hospital care.

Researchers studied the progression-free and overall survival rates of patients with advanced melanoma after cessation of immune checkpoint inhibitor therapy.

A prognostic index can be used to identify patients with estrogen receptor (ER)-positive, HER2-negative early breast cancer who can safely forgo adjuvant chemotherapy as well as patients who require ...

Combination treatment with zanubrutinib and venetoclax has elicited durable responses in patients with treatment-naïve chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and ...

Edward Bittner, Author at Oncology Nurse AdvisorEdward Bittner ...